This talk will introduce and explore, the global mechanisms and initiatives that align process, strategy and methodology for Health Technology Assessment (HTA).
It will introduce and explain the methods behind stakeholder involvement in HTA, with a particular focus on patient involvement. It will explore the benefits and challenges posed by increasing innovation complexity, and explore how new methods and forms of evidence are being used to reduce barriers to patient access and health system financial constraints.
Neil Bertelsen is an independent consultant with over 25 years of experience bringing the patient voice to health care decision-makers and communicating the science of health care to patients in a way that truly informs their own personal health choices. Neil is passionate about bringing the patient experience and perspectives to decision-makers including industry and health technology assessment bodies.
Neil works directly with the patient advocacy community, the industry, and authorities such as HTA agencies to facilitate collaborations and co-creation of approaches to improve access to healthcare and better provision of care. As a facilitator of meetings and advisory boards, Neil has global experience working with multiple stakeholders on demanding issues that require a coordinated response.
This talk was held as part of the Economics and Regulation in Translational Science module which is part of the MSc in Translational Health Sciences.